Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion type Assertion NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_head.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion description "[Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_provenance.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion evidence source_evidence_literature NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_provenance.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion SIO_000772 23648463 NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_provenance.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion wasDerivedFrom befree-20140225 NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_provenance.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion wasGeneratedBy ECO_0000203 NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_provenance.